EP12.01. Combination of Osimertinib plus Capmatinib in a Patient with EGFR-mutant, T790M positive and MET amplification: A Case Report - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Kijjakom Thanasombunsukh
Meta Tag
Speaker Kijjakom Thanasombunsukh
Topic Metastatic NSCLC: Targeted Therapy - EGFR/HER2
Keywords
metastatic non-small cell lung cancer
NSCLC
epidermal growth factor receptor
EGFR mutation
T790M positive
MET amplification
osimertinib
capmatinib
late-line treatment
pulmonary adenocarcinoma
Powered By